(Reuters) – Novavax Inc said on Tuesday its updated protein-based COVID-19 vaccine generated neutralizing antibody responses to the “Eris” subvariant in preclinical studies.
(Reporting by Khushi Mandowara in Bengaluru; Editing by Shilpi Majumdar)
Novavax’s updated COVID vaccine shows response against ‘Eris’ variant
Aug 22, 2023 | 7:16 AM
